AtaiBeckley (ATAI) Other Non Operating Income (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Other Non Operating Income came in at $87000.0 in Q1 2026, down 80.92% year-on-year from $456000.0 in Q1 2025, and down 80.92% quarter-over-quarter from $456000.0 in Q1 2025.
AtaiBeckley (ATAI) Other Non Operating Income (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Other Non Operating Income data on file, last reported at -$650000.0 in Q3 2025.
- For the quarter ending Q3 2025, Other Non Operating Income changed N/A year-over-year to -$650000.0; the trailing twelve-month figure through Sep 2025 stood at -$3.4 million (down 1027.45% YoY), and the FY2024 full-year result was -$1.3 million, down 41.28% from the prior year.
- Other Non Operating Income slipped to $87000.0 in Q1 2026 per ATAI's latest filing, from $456000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $456000.0 in Q1 2025 and bottomed at $87000.0 in Q1 2026.
- A 5-year average of -$53428.6 and a median of -$209000.0 in 2021 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 544.19% in 2024 and surged 9220.0% in 2025, its largest moves.
- Tracing ATAI's Other Non Operating Income over 5 years: stood at $174000.0 in 2021, then sank by 316.67% to -$377000.0 in 2022, then advanced by 20.16% to -$301000.0 in 2023, then sank by 544.19% to -$1.9 million in 2024, then soared by 66.48% to -$650000.0 in 2025.
- Business Quant data shows ATAI's Other Non Operating Income at -$650000.0 in Q3 2025, -$1.3 million in Q2 2025, and $456000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87,000.00 |
| Sep 30, 2025 | -650,000.00 |
| Jun 30, 2025 | -1.32 Mn |
| Mar 31, 2025 | 456,000.00 |
| Mar 31, 2025 | 456,000.00 |
| Dec 31, 2024 | -1.94 Mn |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -301,000.00 |
| Sep 30, 2023 | -308,000.00 |
| Jun 30, 2023 | -9,000.00 |
| Mar 31, 2023 | -837,000.00 |
| Dec 31, 2022 | -377,000.00 |
| Sep 30, 2022 | 4.47 Mn |
| Jun 30, 2022 | 12,000.00 |
| Dec 31, 2021 | 174,000.00 |
| Mar 31, 2021 | -117,000.00 |
| Dec 31, 2020 | 444,000.00 |
| Sep 30, 2020 | -159,000.00 |
| Jun 30, 2020 | -37,000.00 |